Rational Design of a Stable, Freeze-Dried Virus-Like Particle-Based Vaccine Formulation

REFERENCES

• A. M. Abdul-Fattah, V. Truong-Le, L. Yee, E. Pan, Y. Ao, D. S. Kalonia, and M. J. Pikal. (2007). Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on stability II: Stability of a vaccine. Pharm. Res. 24 (4):715–727.
   PubMed Web of Science ®Google Scholar
• A. A. Adebayo, J. W. Sim-Brandenburg, H. Emmel, D. O. Olaleye, and M. Niedrig. (1998). Stability of 17D yellow fever virus vaccine using different stabilizers. Biologicals 26 (4):309–316.
   PubMed Web of Science ®Google Scholar
• S. D. Allison, and T. J. Anchordoquy. (2000). Mechanisms of protection of cationic lipid-DNA complexes during lyophilization. J. Pharm. Sci. 89 (5):682–691.
   PubMed Web of Science ®Google Scholar
• P. M. Ambuehl, A. C. Tissot, A. Fulurija, P. Maurer, J. Nussberger, R. Sabat, V. Nief, C. Schellekens, K. Sladko, K. Roubicek, T. Pfister, M. Rettenbacher, H. D. Volk, F. Wagner, P. Mueller, G. T. Jennings, and M. F. Bachmann. (2007). A vaccine for hypertension based on virus-like particles: Preclinical efficacy and phase I safety and immunogenicity. J. Hypertens. 25 (1):63–72.
   PubMed Web of Science ®Google Scholar
• T. J. Anchordoquy, and J. F. Carpenter. (1996). Polymers protect lactate dehydrogenase during freeze-drying by inhibiting dissociation in the frozen state. Arch. Biochem. Biophys. 332 (2):231–238.
   PubMed Web of Science ®Google Scholar
• T. Arakawa, Y. Kita, and J. F. Carpenter. (1991). Protein-solvent interactions in pharmaceutical formulations. Pharm. Res. 8 (3):285–291.
   PubMed Web of Science ®Google Scholar
• T. Arakawa, and S. N. Timasheff. (1982). Preferential interactions of proteins with salts in concentrated solutions. Biochemistry 21 (25):6545–6552.
   PubMed Web of Science ®Google Scholar
• M. Bachmann, P. Maurer, E. Meijerink, K. Proba, and K. Schwarz. 2006. Virus-like particle-antigen conjugates and their uses as vaccines. European Patent EP2006037787.
   Google Scholar
• M. F. Bachmann, U. H. Rohrer, T. M. Kuendig, K. Buerki, H. Hengartner, and R. M. Zinkernagel. (1993). The influence of antigen organization on B cell responsiveness. Science 262 (5138):1448–1451.
   PubMed Web of Science ®Google Scholar
• N. B. Bam, T. W. Randolph, and J. L. Cleland. (1995). Stability of protein formulations: Investigation of surfactant effects by a novel EPR spectroscopic technique. Pharm. Res. 12 (1):2–11.
   PubMed Web of Science ®Google Scholar
• D. Beckett, H. N. Wu, and O. C. Uhlenbeck. (1988). Roles of operator and non-operator RNA sequences in bacteriophage R17 capsid assembly. J. Mol. Biol. 204 (4):939–947.
   PubMed Web of Science ®Google Scholar
• R. M. Bieganski, A. Fowler, J. R. Morgan, and M. Toner. (1998). Stabilization of active recombinant retroviruses in an amorphous dry state with trehalose. Biotechnol. Prog. 14 (4):615–620.
   PubMed Web of Science ®Google Scholar
• S. L. Block, T. Nolan, C. Sattler, E. Barr, Katherine Giacoletti, E. D. Marchant, C. D. Castellsague, X. Rusche, S. A. Lukac, S. Bryan, J. T. Cavanaugh, P. F. Jr, and K. S. Reisinger. (2006). Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women. Pediatrics 118 (5):2135–2145.
   PubMed Web of Science ®Google Scholar
• D. T. Brandau, L. S. Jones, C. M. Wiethoff, J. Rexroad, and C. R. Middaugh. (2003). Thermal stability of vaccines. J. Pharm. Sci. 92 (2):218–231.
   PubMed Web of Science ®Google Scholar
• J. F. Carpenter, S. J. Prestrelski, T. J. Anchordoguy, and T. Arakawa. (1994). Interactions of stabilizers with proteins during freezing and drying. ACS Symp. Ser. 567:134–147.
   Google Scholar
• B. S. Chang, B. S. Kendrick, and J. F. Carpenter. (1996). Surface-induced denaturation of proteins during freezing and its inhibition by surfactants. J. Pharm. Sci. 85 (12):1325–1330.
   PubMed Web of Science ®Google Scholar
• B. S. Chang, and C. S. Randall. (1992). Use of subambient thermal analysis to optimize protein lyophilization. Cryobiology 29 (5):632–656.
   Web of Science ®Google Scholar
• L. Chang, D. Sheperd, J. Sun, D. Ouellette, K. L. Grant, X. Tang, and M. J. Pikal. (2005). Mechanism of protein stabilization by sugars during freeze-drying and storage: Native structure preservation, specific interaction, and/or immobilization in a glassy matrix?. J. Pharm. Sci. 94 (7):1427–1444.
   PubMed Web of Science ®Google Scholar
• Y. P. Chuan, Y. Y. Fan, L. Lua, and A. P. J. Middelberg. (2008). Quantitative analysis of virus-like particle size and distribution by field-flow fractionation. Biotechnol. Bioeng. 99 (6):1425–1433.
   PubMed Web of Science ®Google Scholar
• J. H. Crowe, J. F. Carpenter, and L. M. Crowe. (1998). The role of vitrification in anhydrobiosis. Annu. Rev. Physiol. 60:73–103.
   PubMed Web of Science ®Google Scholar
• J. H. Crowe, L. M. Crowe, and J. F. Carpenter. (1993a). Preserving dry biomaterials: The water replacement hypothesis. Part 2. Bio. Pharm. 6 (4):40–43.
   Google Scholar
• J. H. Crowe, L. M. Crowe, and J. F. Carpenter. (1993b). Preserving dry biomaterials: The water replacement hypothesis. Part 1. BioPharm. 6 (3):28–29.32.
   Google Scholar
• L. M. Crowe, D. S. Reid, and J. H. Crowe. (1996). Is trehalose special for preserving dry biomaterials?. Biophys. J. 71 (4):2087–2093.
   PubMed Web of Science ®Google Scholar
• P. E. Cruz, A. C. Silva, A. Roldao, M. Carmo, M. J. T. Carrondo, and P. M. Alves. (2006). Screening of novel excipients for improving the stability of retroviral and adenoviral vectors. Biotechnol. Prog. 22 (2):568–576.
   PubMed Web of Science ®Google Scholar
• A. Engel, G. Bendas, F. Wilhelm, M. Mannova, M. Ausborn, and P. Nuhn. (1994). Freeze drying of liposomes with free and membrane-bound cryoprotectants—the background of protection and damaging processes. Int. J. Pharm. 107 (2):99–110.
   Web of Science ®Google Scholar
• R. K. Evans, D. K. Nawrocki, L. A. Isopi, D. M. Williams, D. R. Casimiro, S. Chin, M. Chen, D. M. Zhu, J. W. Shiver, and D. B. Volkin. (2004). Development of stable liquid formulations for adenovirus-based vaccines. J. Pharm. Sci. 93 (10):2458–2475.
   PubMed Web of Science ®Google Scholar
• F. Franks. (1998). Freeze-drying of bioproducts: putting principles into practice. Eur. J. Pharm. Biopharm. 45 (3):221–229.
   PubMed Web of Science ®Google Scholar
• W. Fraunhofer, and G. Winter. (2004). The use of asymmetrical flow field-flow fractionation in pharmaceutics and biopharmaceutics. Eur. J. Pharm. Biopharm. 58 (2):369–383.
   PubMed Web of Science ®Google Scholar
• J. P. Gabrielson, M. L. Brader, A. H. Pekar, K. B. Mathis, G. Winter, J. F. Carpenter, and T. W. Randolph. (2006). Quantitation of aggregate levels in a recombinant humanized monoclonal antibody formulation by size-exclusion chromatography, asymmetrical flow field flow fractionation, and sedimentation velocity. J. Pharm. Sci. 96 (2):268–279.
   Web of Science ®Google Scholar
• J. C. Giddings (2000). Field flow fractionation handbook. New York: John Wiley & sons, Inc.
   Google Scholar
• C. K. Gupta, J. Leszczynski, R. K. Gupta, and G. R. Siber. (1996). Stabilization of respiratory syncytial virus (RSV) against thermal inactivation and freeze-thaw cycles for development and control of RSV vaccines and immune globulin. Vaccine 14 (15):1417–1420.
   PubMed Web of Science ®Google Scholar
• A. Hawe, and W. Friess. (2006). Physico-chemical lyophilization behavior of mannitol, human serum albumin formulations. Eur. J. Pharm. Sci. 28 (3):224–232.
   PubMed Web of Science ®Google Scholar
• W. L. J. Hinrichs, N. N. Sanders, S. C. De Smedt, J. Demeester, and H. W. Frijlink. (2005). Inulin is a promising cryo- and lyoprotectant for PEGylated lipoplexes. J. Control. Release 103 (2):465–479.
   PubMed Web of Science ®Google Scholar
• T. Hohn, and B. Hohn. (1970). Structure and assembly of simple RNA bacteriophages. Adv. Virus Res. 16:43–98.
   PubMedGoogle Scholar
• K. Izutsu, and S. Kojima. (2002). Excipient crystallinity and its protein-structure-stabilizing effect during freeze-drying. J. Pharm. Pharmacol. 54 (8):1033–1039.
   PubMed Web of Science ®Google Scholar
• R. E. Johnson, C. F. Kirchhoff, and H. T. Gaud. (2002). Mannitol-sucrose mixtures-versatile formulations for protein lyophilization. J. Pharm. Sci. 91 (4):914–922.
   PubMed Web of Science ®Google Scholar
• L. S. Jones, T. W. Randolph, U. Kohnert, A. Papadimitriou, G. Winter, M. L. Hagmann, M. C. Manning, and J. F. Carpenter. (2001). The effects of Tween 20 and sucrose on the stability of anti-L-selectin during lyophilization and reconstitution. J. Pharm. Sci. 90 (10):1466–1477.
   PubMed Web of Science ®Google Scholar
• L. Kreilgaard, L. S. Jones, T. W. Randolph, S. Frokjaer, J. M. Flink, M. C. Manning, and J. F. Carpenter. (1998). Effect of tween 20 on freeze-thawing- and agitation-induced aggregation of recombinant human factor XIII. J. Pharm. Sci. 87 (12):1597–1603.
   PubMed Web of Science ®Google Scholar
• R. Lang, and G. Winter (2006). http://www.wyatt.com/literature/Field_Flow_Fractionation-vlp.pdf Characterization of virus like particles by asymmetrical flow field-flow fractionation, Application notes. Wyatt Technology Corpt.
   Google Scholar
• F. Lechner, A. Jegerlehner, A. C. Tissot, P. Maurer, P. Sebbel, W. A. Renner, G. T. Jennings, and M. F. Bachmann. (2002). Virus-like particles as a modular system for novel vaccines. Intervirology 45 (4–6):212–217.
   PubMed Web of Science ®Google Scholar
• H. Levine, and L. Slade. (1988). Principles of “cryostabilization” technology from structure/property relationships of carbohydrate/water systems—a review. Cryo-Letters 9 (1):21–63.
   Google Scholar
• X. Liao, R. Krishnamurthy, and R. Suryanarayanan. (2005). Influence of the active pharmaceutical ingredient concentration on the physical state of mannitol-implications in freeze-drying. Pharm. Res. 22 (11):1978–1985.
   PubMed Web of Science ®Google Scholar
• P. Maurer, and M. F. Bachmann. (2006). Therapeutic vaccines for nicotine dependence. Curr. Opin. Mol. Ther. 8 (1):11–16.
   PubMed Web of Science ®Google Scholar
• P. Maurer, G. T. Jennings, J. Willers, F. Rohner, Y. Lindman, K. Roubicek, W. A. Renner, P. Mueller, and M. F. Bachmann. (2005). A therapeutic vaccine for nicotine dependence: Preclinical efficacy, and phase I safety and immunogenicity. Eur. J. Immunol. 35 (7):2031–2040.
   PubMed Web of Science ®Google Scholar
• M. Molina, T. K. Armstrong, Y. Zhang, M. M. Patel, Y. K. Lentz, and T. J. Anchordoquy. (2004). The stability of lyophilized lipid/DNA complexes during prolonged storage. J. Pharm. Sci. 93 (9):2259–2273.
   PubMed Web of Science ®Google Scholar
• J. S. Philo. (2006). Is any measurement method optimal for all aggregate sizes and types?. AAPS J. 8 (3):E564–E571.
   PubMed Web of Science ®Google Scholar
• M. J. Pikal. (2004). Mechanisms of protein stabilization during freeze-drying and storage: The relative importance of thermodynamic stabilization and glassy state relaxation dynamics. Drugs Pharm. Sci. 137:63–107.
   Google Scholar
• S. Prestrelski, N. Tedeschi, T. Arakawa, and J. F. Carpenter. (1993). Dehydration-induced conformational transitions in proteins and their inhibition by stabilizers. Biophys. J. 65 (2):661–671.
   PubMed Web of Science ®Google Scholar
• P. Reschiglian, A. Zattoni, B. Roda, E. Michelini, and A. Roda. (2005). Field-flow fractionation and biotechnology. Trends Biotechnol. 23 (9):475–483.
   PubMed Web of Science ®Google Scholar
• J. Rexroad, C. M. Wiethoff, L. S. Jones, and C. R. Middaugh. (2002). Lyophilization and the thermostability of vaccines. Cell Preserv. Technol. 1 (2):91–104.
   Google Scholar
• S. Russo, L. Turin, A. Zanella, W. Ponti, and G. Poli. (1997). What's going on in vaccine technology?. Med. Res. Rev. 17 (3):277–301.
   PubMed Web of Science ®Google Scholar
• N. C. Santos, and M. A. R. B. Castanho. (1996). Teaching light scattering spectroscopy: the dimension and shape of tobacco mosaic virus. Biophys. J. 71 (3):1641–1650.
   PubMed Web of Science ®Google Scholar
• J. M. Sarciaux, S. Mansour, M. J. Hageman, and S. L. Nail. (1999). Effects of buffer composition and processing conditions on aggregation of bovine IgG during freeze-drying. J. Pharm. Sci. 88 (12):1354–1361.
   PubMed Web of Science ®Google Scholar
• J. Sarkar, B. P. Sreenivasa, R. P. Singh, P. Dhar, and S. K. Bandyopadhyay. (2003). Comparative efficacy of various chemical stabilizers on the thermostability of a live-attenuated peste des petits ruminants (PPR) vaccine. Vaccine 21 (32):4728–4735.
   PubMed Web of Science ®Google Scholar
• J. J. Schwegman, L. M. Hardwick, and M. J. Akers. (2005). Practical formulation and process development of freeze-dried products. Pharm. Dev. Technol. 10 (2):151–173.
   PubMed Web of Science ®Google Scholar
• E. M. Scott, and W. Woodside. (1976). Stability of pseudorabies virus during freeze-drying and storage: effect of suspending media. J. Clin. Microbiol. 4 (1):1–5.
   PubMed Web of Science ®Google Scholar
• L. Shi, G. Sanyal, A. Ni, Z. Luo, S. Doshna, B. Wang, T. L. Graham, N. Wang, and D. B. Volkin. (2005). Stabilization of human papillomavirus virus-like particles by non-ionic surfactants. J. Pharm. Sci. 94 (7):1538–1551.
   PubMed Web of Science ®Google Scholar
• H. Talsma, J. Y. Cherng, H. Lehrmann, M. Kursa, M. Ogris, W. E. Hennink, M. Cotten, and E. Wagner. (1997). Stabilization of gene-delivery systems by freeze-drying. Int. J. Pharm. 157 (2):233–238.
   PubMed Web of Science ®Google Scholar
• X. Tang, and M. J. Pikal. (2004). Design of freeze-drying processes for pharmaceuticals: Practical advice. Pharm. Res. 21 (2):191–200.
   PubMed Web of Science ®Google Scholar
• W. Wang. (2000). Lyophilization and development of solid protein pharmaceuticals. Int. J. Pharm. 203 (1–2):1–60.
   PubMed Web of Science ®Google Scholar
• E. E. Worrall, J. K. Litamoi, B. M. Seck, and G. Ayelet. (2001). Xerovac: An ultra rapid method for the dehydration and preservation of live attenuated Rinderpest and Peste des Petits ruminants vaccines. Vaccine 19 (7–8):834–839.
   Web of Science ®Google Scholar
• S. Zhai, R. K. Hansen, R. Taylor, J. N. Skepper, R. Sanches, and N. K. H. Slater. (2004). Effect of freezing rates and excipients on the infectivity of a live viral vaccine during lyophilization. Biotechnol. Prog. 20 (4):1113–1120.
   PubMed Web of Science ®Google Scholar
• J. Zillies (2007). Gelatin nanoparticles for targeted oligonucleotide delivery to kupffer cells—analytics, formulation development, practical application. Munich: Verlag Dr. Hut.
   Google Scholar
• C. Zingel, A. Sachse, G. L. Roessling, and R. H. Mueller. (1996). Lyophilization and rehydration of iopromide-carrying liposomes. Int. J. Pharm. 140 (1):13–24.
   Web of Science ®Google Scholar